Adiponectin, systolic blood pressure, and alcohol consumption are associated with more aortic stiffness progression among apparently healthy men
OBJECTIVE: Limited data are available about risk factors for the progression of aortic stiffness in healthy population. We examined several risk factors as possible independent predictors of aortic stiffness progression among a population-based sample of US men.
METHODS: A total of 240 men (40-49 years) free of CVD at baseline from the Pittsburgh site of the ERA JUMP study were evaluated. Aortic stiffness was measured as carotid-femoral pulse wave velocity at baseline and after 4.6 +/- 0.2 (mean +/- SD) years of follow-up. Progression of aortic stiffness was evaluated as relative annual change in carotid-femoral pulse wave velocity (% change/year). Using linear regression, both baseline potential risk factors and their annual changes were evaluated as possible risk factors for aortic stiffness progression. Baseline age, follow-up time, race, heart rate, and medications use were forced in all models.
RESULTS: During follow-up, relative to baseline level, aortic stiffness increased 0.3% +/- 5.3% per year. In final models, the independent predictors of degree of aortic stiffness progression were lower levels of adiponectin (P = 0.03), higher levels of systolic blood pressure (P = 0.03), greater annual change in systolic blood pressure (P = 0.04), and alcohol consumption >/= 2 times/week (P = 0.02). Adiponectin levels within the third (9.8 mug/Ml /= 13.0 mug/mL) quartiles were associated with an improvement in relative annual aortic stiffness progression (P = 0.02, P = 0.01, respectively) compared to levels within the first quartile (adiponectin </= 7.0 mug/mL).
CONCLUSION: Among apparently healthy men, lower levels of baseline adiponectin could be a novel marker for greater risk of aortic stiffness progression. Longitudinal research is required to evaluate whether adiponectin change over time would have similar association with aortic stiffness progression.
Additional Info
-
Authors
El Khoudary S.R.; Barinas-Mitchell E.; White J.; Sutton-Tyrrell K.; Kuller L.H.; Curb J.D.; Shin C.; Ueshima H.; Masaki K.; Evans R.W.; Miura K.; Edmundowicz D.; Sekikawa A. -
Issue
Atherosclerosis / pages 475-480 / volume 225 -
Published Date
december 2012
Related items
- Alcohol and Cardiovascular Disease
- Alcohol Consumption and Acute Coronary Syndrome: Epidemiology, Pathophysiology, and Clinical Perspectives
- Urinary polyphenol signature of the Mediterranean diet is associated with lower cardiovascular disease risk: the PREDIMED trial
- The Mediterranean diet and cardiovascular disease
- Blood Pressure After Changes in Light-to-Moderate Alcohol Consumption in Women and Men: Longitudinal Japanese Annual Checkup Analysis